Oaktree Acquisition Corp. III Life Sciences (OACC) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2025-10-29 | 8-K | Officer / Director Changes | SEC |
| 2025-10-17 | 8-K | Officer / Director Changes | SEC |
| 2025-06-06 | 8-K | Officer / Director Changes | SEC |
| 2025-01-07 | 8-K | Officer / Director Changes | SEC |
| 2024-12-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-05 | 8-K | Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-31 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-25 | 8-K | Material Agreement, Unregistered Sales, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.